Latest news
Loading news…
Chatham Therapeutics
Chapel Hill, North Carolina, United States
Chatham Therapeutics is engaged in the development of gene-based therapy technologies focused on hemophilia.
Chatham Therapeutics was acquired by Baxter International in 2014 for $70M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Chapel Hill, North Carolina, United States
- Diversity spotlight
- Women Founded
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Chatham Therapeutics
Loading news…
FAQs about Chatham Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.